EndoChoice, De Lage Landen Financial Services collaborate, Spring Bank Pharmaceutical appoints CMO — 4 GI/endoscopy company key notes

Here are four news updates on key gastroenterology and endoscopy companies.

EndoChoice has a consensus revenue estimate of $74.51 million for fiscal year 2015.

EndoChoice is collaborating with De Lage Landen Financial Services to create a new financing option for customers interested in its Fuse Endoscopy system.

Clinical-stage biopharmaceutical company Spring Bank Pharmaceutical appointed Nezam Afdhal, MD, CMO.

Olympus introduced its CleverCut3V Distal Wireguided sphincterotome.

More articles on GI/endoscopy:
Exact Sciences to open biotech campus & more – 3 GI company key notes
CMS cuts to colonoscopy reimbursement finalized: 3 things to know
6 recent must-reads on CRC screening & treatments

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months